Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-732-6 | CAS number: 10339-55-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 3,7-dimethylnona-1,6-dien-3-ol
- EC Number:
- 233-732-6
- EC Name:
- 3,7-dimethylnona-1,6-dien-3-ol
- Cas Number:
- 10339-55-6
- Molecular formula:
- C11H20O
- IUPAC Name:
- 3,7-dimethylnona-1,6-dien-3-ol
- Details on test material:
- - Purity: >97%
Constituent 1
- Specific details on test material used for the study:
- purity 98.1%
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
-Source: Envigo RMS B.V., Inc
- Age at study initiation:
pre-test: 11 - 12 weeks
main study: 7 - 11 weeks
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 25, 50 and 100 %
- No. of animals per dose:
- 5
- Details on study design:
- Three groups each of five female mice were treated with different concentrations of the test item by topical application at the dorsum of each ear once daily each on three consecutive days. A control group of five mice was treated with the vehicle only. Five days after the first topical
application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine; 3HTdR). Approximately five
hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes were excised and pooled per animal. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic
acid overnight. The proliferative capacity of pooled lymph node cells were then determined by the incorporation of 3H-methyl thymidine
measured in a β-scintillation counter. - Statistics:
- All calculations conducted on the DPM values and the ear weights were performed with a validated test script of “R”, a language and environment for statistical computing and graphics.
Results and discussion
- Positive control results:
- The sensitivity and reliability of the experimental technique employed was assessed by use of α-hexyl cinnamaldehyde dissolved in acetone/olive oil (4+1 v/v) (compound listed in OECD 429 Guideline) which is known to have skin sensitisation properties in mice. The periodic positive control experiment was performed using CBA/CaOlaHsd mice in April 2016.
Results:
10 % α-hexyl cinnamaldehyde dissolved in acetone/olive oil (4+1 v/v): SI = 2.79
25 % α-hexyl cinnamaldehyde dissolved in acetone/olive oil (4+1 v/v) : SI = 7.84
EC3 = 10.6% (w/v)
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- vehicle control group (DMF)
- Key result
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- 25 % Ethyllinalool
- Key result
- Parameter:
- SI
- Value:
- 3.1
- Test group / Remarks:
- 50 % Ethyllinalool
- Key result
- Parameter:
- SI
- Value:
- 4
- Test group / Remarks:
- 100 % Ethyllinalool
- Key result
- Parameter:
- other: desintegration per minute (DPM)
- Value:
- 6 099.5
- Test group / Remarks:
- mean DPM per animal; SD 1132.8
Any other information on results incl. tables
EC3 = 48.2 % (w/v)
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test item Ethyllinalool was found to be a skin sensitizer and an EC3 value of 48.2 % (w/v) was derived.
- Executive summary:
In the study, the test item Ethyllinalool formulated in water-free dimethylformamide (DMF) was assessed for its possible skin sensitising potential. For this purpose a local lymph node assay was performed using test item concentrations of 25, 50, and 100 % (w/v). Clinical signs in the main experiment included squinted or closed eyes, mainly up to 1 h after application, as well as a very mild to moderate (score 1 -2) erythema of the ear skin, and scaly ears in all animals. A statistically significant or biologically relevant increase in ear weights was not observed in any dose group.
In this study Stimulation Indices (S.I.) of 1.7, 3.1, and 4.0 were determined with the test item at concentrations of 25, 50, and 100% in water-free DMF, respectively. A clear dose-response was observed.
The test item Ethylliinalool was found to be a skin sensitiser and an EC3 value of 48.2 % (w/v) was derived.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.